Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: Possible mechanisms involved

Hypertension

Volumn 28, Issue 4, 1996, Pages 583-592

  Angulo, Javier ^a   Sánchez Ferrer, Carlos F ^a   Peiró, Concepción ^a   Marín, Jesús ^a   Rodríguez Mañas, Leocadio ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

diabetes; endothelium; glycosylated; hemoglobin A; nitric oxide; vascular diseases

Indexed keywords

7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR ANTAGONIST; FREE RADICAL; GLYCOSYLATED HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE INHIBITOR; SCAVENGER; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; XANTHINE OXIDASE;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0029820473     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.4.583     Document Type: Article

References (56)

1. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19:403-418.
2. The National High Blood Pressure Education Program Working Group. Report on hypertension in diabetes. Hypertension. 1994; 23:145-158.
3. Fortes ZB, Lerne JG, Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cells. Br J Pharmacol. 1983;79: 771-781.
4. Calvier A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992;90:2548-2554.
5. McVeigh GE, Brennan GM, Johnson GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:771-776.
6. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
7. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993;87(suppl V):V-67-V-76.
8. Winegrad AI, Simmons DA. Mechanisms of early hyperglycemiainduced alterations in vascular metabolism and autoregulation. In: Ruderman N, Williamson J, Brownlee M, eds. Hyperglycemia, Diabetes and Vascular Disease. New York, NY: Oxford University Press; 1990:133-150.
9. +-ATPaSe activity in rabbit aorta by hyperglycemia: possible role of endothelium-derived nitric oxide. J Clin Invest. 1992;90:727-732.
10. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aona. Am J Physiol. 1991;261:H1086-H1094.
11. Tesfamarian B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med. 1994;16:383-391.
12. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest. 1991;87: 432-438,
13. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA. 1992;89:12043-12047.
14. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceril trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985;232:708-716.
15. Rodríguez-Mañas L, Arribas S, Girón C, Villamor J, Sánchez-Ferrer CF, Marín J. Interference of glycosylated human hemoglobin with endothelium-dependent responses. Circulation. 1993;88:2111-2116.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
17. Dahl-Jörgensen K, Hanssen KF, Kierulf P, Björo T, Sandvik L, Aagenaes Ö. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus: The Oslo Study. Acta Endocrinol. 1988;117:19-25.
18. Reichard P, Berglund B, Vritz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study after five years. J Intern Med. 1991;230:101-108.
19. Feldt-Rasmussen B, Mathiessen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia. 1991;34:164-170.
20. Ziegler D, Mayer P, Mühlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991;34:822-829.
21. Brinchmann-Hansen O, Dahl-Jörgensen K, Sandvik L, Hanssen FK. Blood glucose concentrations and progression of diabetic retinopathy: the seven years results of the Oslo study. Br Med J. 1992;304: 19-22.
22. 1c assay. Clin Lab. 1993;39:991-996.
23. Sánchez-Ferrer CF, Fernández-Alfonso MS, Ponte A, Casado MA, Gonzalez R, Rodríguez-Mañas L, Pareja A, Marín J. Endothelial modulation of the ouabain-induced contraction in human placental vessels. Circ Res. 1992;71:943-950.
24. Alonso MJ, Salaices M, Sánchez-Ferrer CF, Ponte A, Lopez-Rico M, Marin J. Nitric-oxide-related and non-related mechanisms in the acetylcholine-evoked relaxations in cat femoral arteries. J Vasc Res. 1993;30:339-347.
25. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 1992;263:H257-H265.
26. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension. 1990;15:699-703.
27. Ogletree ML, Allen GT. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscle. J Pharmacol Exp Ther. 1992;260: 789-794.
28. Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension. 1993;21:9-19.
29. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 1992;267:5133-5138.
30. Tentori L, Salvati AM. Hemoglobinometry in human blood. In: Antonini E, Rossi-Bernardi L, Chiancone E, eds. Methods in Enzymology. New York, NY: Academic Press, Inc; 1981;76:707-715.
31. Jovanovic L, Peterson CM. The clinical utility of glycosyated hemoglobin. Am J Med. 1981;70:331-337.
32. Tietz NW. Clinical Guide to Laboratory Tests. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990.
33. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Circulation. 1992;85:391-405.
34. Taylor PD, Wickenden AD, Mirrlees DJ, Poston L. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmacol. 1994;111:42-48.
35. Gerard D. The effect of intensive treatment of diabetes mellitus. N Engl J Med. 1994;330:642. Letter.
36. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes-mellitus. N Engl J Med. 1995;332:1251-1255.
37. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes-mellitus. N Engl J Med. 1995;332:1305-1306.
38. Viberti G. A glycemic threshold for diabetic complications? N Engl J Med. 1995;332:1293-1294.
39. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thein T. Endotheliumdependent vascular relaxation in patients with type I diabetes. Diabetes. 1993;42:148-153.
40. Pieper GM, Jordan M, Adamas MB, Roza AM. Syngeneic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes. Diabetes. 1995;44:1106-1115.
41. 2. Am J Physiol. 1989;257:H1327-H1333.
42. Tesfamarian B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 1990;85:929-932.
43. Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol. 1993;265:H219-H225.
44. Heygate KM, Lawrence IG, Bennet MA, Thurston H. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol. 1995;116:3251-3259.
45. 8 receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
46. Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation. 1994;89:1320-1322.
47. Takeda Y, Migamori Y, Yoneda T, Takeda R. Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. Life Sci. 1991;48:2553-2556.
48. Takahashi K, Ghatei MA, Lam H-C, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990;33:306-310.
49. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of desferoxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med. 1995;18:833-840.
50. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 1990;173:932-939.
51. Pieper GM, Gross GJ. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 1988; 255:H825-H833.
52. Tesfamarian B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263: H321-H326.
53. Diederich D, Skopec J, Diederich A, Dai F-X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol. 1994;266:H1153-H1161.
54. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biological and clinical implications for diabetes and aging. Lab Invest. 1994;70:138-151.
55. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science. 1992;258:651-653.
56. Kristal BS, Yu BP. An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions. J Gerontol. 1992; 47:B107-B114.